This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Connolly, P. A.
Right arrow Articles by Wheat, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Connolly, P. A.
Right arrow Articles by Wheat, L. J.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, December 2007, p. 1587-1591, Vol. 14, No. 12
1071-412X/07/$08.00+0     doi:10.1128/CVI.00071-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Detection of Histoplasma Antigen by a Quantitative Enzyme Immunoassay{triangledown}

Patricia A. Connolly,* Michelle M. Durkin, Ann M. LeMonte, Emily J. Hackett, and L. Joseph Wheat

MiraVista Diagnostics and Mirabella Technologies, Indianapolis, Indiana

Received 7 February 2007/ Returned for modification 24 May 2007/ Accepted 14 September 2007

The second-generation Histoplasma antigen immunoassay is semiquantitative, expressing results as a comparison to a negative control, which requires repeat testing of the prior specimen with the current specimen to accurately determine a change in antigen. Reporting results in this manner often is confusing to the ordering physician and laboratory. Development of a quantitative assay could improve accuracy, reduce interassay variability, and eliminate the need to test the prior sample with the current sample in the same assay. Calibrators with known concentrations of Histoplasma antigen were used to quantitate antigen in specimens from patients with histoplasmosis and from controls. Samples from cases of disseminated histoplasmosis or other mycoses and controls were tested to evaluate the performance characteristics of the quantitative assay. Paired specimens were evaluated to determine if quantitation eliminated the need to test the current and prior specimens in the same assay to assess a change in antigen. The sensitivity in samples from patients with AIDS and disseminated histoplasmosis was 100% in urine and 92.3% in serum. Cross-reactions occurred in 70% of other endemic mycoses, but not in aspergillosis. Specificity was 99% in controls with community-acquired pneumonia, medical conditions in which histoplasmosis was excluded, or healthy subjects. A change in antigen level categorized as an increase, no change, or decrease based on antigen units determined in the same assay agreed closely with the category of change in nanograms/milliliter determined from testing current and prior specimens in different assays. Sensitivity, specificity, and interassay precision are excellent in the new third-generation quantitative Histoplasma antigen immunoassay.

* Corresponding author. Mailing address: MiraVista Diagnostics, 4444 Decatur Blvd., Indianapolis, IN 46241. Phone: (317) 856-2681, ext. 451. Fax: (317) 856-3685. E-mail: pconnolly{at}miravistalabs.com

{triangledown} Published ahead of print on 3 October 2007.

Clinical and Vaccine Immunology, December 2007, p. 1587-1591, Vol. 14, No. 12
1071-412X/07/$08.00+0     doi:10.1128/CVI.00071-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Durkin, M., Estok, L., Hospenthal, D., Crum-Cianflone, N., Swartzentruber, S., Hackett, E., Wheat, L. J. (2009). Detection of Coccidioides Antigenemia following Dissociation of Immune Complexes. CVI 16: 1453-1456 [Abstract] [Full Text]  
  • Frank, K. M., Hogarth, D. K., Miller, J. L., Mandal, S., Mease, P. J., Samulski, R. J., Weisgerber, G. A., Hart, J. (2009). Investigation of the Cause of Death in a Gene-Therapy Trial. NEJM 361: 161-169 [Abstract] [Full Text]  
  • Scheel, C. M., Samayoa, B., Herrera, A., Lindsley, M. D., Benjamin, L., Reed, Y., Hart, J., Lima, S., Rivera, B. E., Raxcaco, G., Chiller, T., Arathoon, E., Gomez, B. L. (2009). Development and Evaluation of an Enzyme-Linked Immunosorbent Assay To Detect Histoplasma capsulatum Antigenuria in Immunocompromised Patients. CVI 16: 852-858 [Abstract] [Full Text]  
  • Swartzentruber, S., LeMonte, A., Witt, J., Fuller, D., Davis, T., Hage, C., Connolly, P., Durkin, M., Wheat, L. J. (2009). Improved Detection of Histoplasma Antigenemia following Dissociation of Immune Complexes. CVI 16: 320-322 [Abstract] [Full Text]  
  • Gutierrez, M. E., Canton, A., Connolly, P., Zarnowski, R., Wheat, L. J. (2008). Detection of Histoplasma capsulatum Antigen in Panamanian Patients with Disseminated Histoplasmosis and AIDS. CVI 15: 681-683 [Abstract] [Full Text]  
  • Egan, L., Connolly, P. A., Fuller, D., Davis, T. E., Witt, J. III, Knox, K. S., Hage, C. A., Wheat, L. J. (2008). Detection of Histoplasma capsulatum Antigenuria by Ultrafiltration of Samples with False-Negative Results. CVI 15: 726-728 [Abstract] [Full Text]  
  • Zhuang, D., Hage, C., De Jesus, M., Hackett, E., Durkin, M., Davis, T. E., Casadevall, A., Wheat, L. J. (2008). Cryptococcal Glucoxylomannan Does Not Exhibit Cross-Reactivity in the MVista Histoplasma Antigen Enzyme Immunoassay. CVI 15: 392-393 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»